Abstract
A patient with the neuroleptic malignant syndrome was described whose excessive catecholamine excretion indicated hyperactivity of the sympathoadrenomedullary component of the autonomic nervous system. A physiological basis for using catecholamine blocking agents to treat some patients with this syndrome was discussed.

This publication has 4 references indexed in Scilit: